We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Test Selectively Identifies Influenza A Virus H1N1

By LabMedica International staff writers
Posted on 11 May 2009
A test that has been developed for the new variant of the influenza A virus H1N1 will be launched initially in Europe and Asia.

TIB Molbiol (Berlin, Germany), a cooperation partner of Roche Applied Science (Indianapolis, IN, USA), announced that the company's LightMix A test has been optimized for Roche LightCycler 480 II, 2.0, and 1.2 systems and selectively identifies the new Influenza A H1N1 virus.

"We are proud of our contribution in the battle against a potential pandemic. More...
The new test proved its suitability this week, after identifying the virus in sample materials from Mexico," said Olfert Landt, TIB Molbiol.

Currently, there is no human vaccine on the market that protects against infection by influenza A virus H1N1. Standard therapy for the disease includes treatment with antiviral drugs such as Tamiflu or Relenza.

TIB Molbiol offers custom synthesis of oligonucleotides to a growing number of customers worldwide and is one of the first suppliers of synthetic DNA on the European market. The core competence of the company lies in the development of real-time polymerase chain reaction (RT-PCR) assays for medical diagnostics, life science research, and environmental analysis.

Related Links:
TIB Molbiol
Roche Applied Science


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.